Hemispherx BioPharma (HEB)

[Zunobira]

Why approval chance is very high this time

There is no approved drug for CFS right now. Even though FDA refused to approve Ampligen back in 2009, they did not close the door. Rather FDA kept the case open for HEB to come back with the additional info they need and to file NDA. And we have seen the result - NDA filed and decision coming in Feb 2013. Keep in mind that USA losing huge manpower and productivity each year due to CFS and a treatment is absolute necessity. Also 2012-2014 will be biotech year..several drugs got approval and many in pipeline to get approval.

What could be the stock price on approval? $15...$20? Any thought?